 | TYT | Name: | TYROSINE DERIVATIVE | Formula: | C18 H20 N2 O4 | SMILES: | O=C(O)C(N)CC3C(=O)C=C(O)/C(=N/C2CC2c1ccccc1)C3 | InChi: | InChI=1S/C18H20N2O4/c19-13(18(23)24)6-11-7-15(17(22)9-16(11)21)20-14-8-12(14)10-4-2-1-3-5-10/h1-5,9,11-14,22H,6-8,19H2,(H,23,24)/b20-15+ | Synonyms: | 2-AMINO-3-[4-HYDROXY-6-OXO-3-(2-PHENYL-CYCLOPROPYLIMINO)-CYCLOHEXA-1,4-DIENYL]-PROPIONIC ACID | Definition date: | 2002-06-21 | Last modified: | 2024-09-27 | Identifier: | 3-{(5E)-4-hydroxy-2-oxo-5-[(2-phenylcyclopropyl)imino]cyclohex-3-en-1-yl}alanine |
|
 | WTV | Name: | N-[(benzyloxy)carbonyl]-4-fluoro-L-phenylalanyl-N-{(2R)-1-[(2R)-oxolan-2-yl]-3-[(3R)-2-oxooxolan-3-yl]propan-2-yl}-L-leucinamide | Formula: | C34 H44 F N3 O7 | SMILES: | Fc1ccc(cc1)CC(NC(=O)OCc1ccccc1)C(=O)NC(CC(C)C)C(=O)NC(CC1CCCO1)CC1CCOC1=O | InChi: | InChI=1S/C34H44FN3O7/c1-22(2)17-29(31(39)36-27(20-28-9-6-15-43-28)19-25-14-16-44-33(25)41)37-32(40)30(18-23-10-12-26(35)13-11-23)38-34(42)45-21-24-7-4-3-5-8-24/h3-5,7-8,10-13,22,25,27-30H,6,9,14-21H2,1-2H3,(H,36,39)(H,37,40)(H,38,42)/t25-,27+,28+,29-,30-/m0/s1 | Definition date: | 2023-10-12 | Last modified: | 2024-09-27 | Release date: | 2024-02-14 | Identifier: | N-[(benzyloxy)carbonyl]-4-fluoro-L-phenylalanyl-N-{(2R)-1-[(2R)-oxolan-2-yl]-3-[(3R)-2-oxooxolan-3-yl]propan-2-yl}-L-leucinamide |
|
 | URE | Name: | UREA | Formula: | C H4 N2 O | SMILES: | O=C(N)N | InChi: | InChI=1S/CH4N2O/c2-1(3)4/h(H4,2,3,4) | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | urea |
|
 | RJA | Name: | Ratjadone A, bound form | Formula: | C28 H44 O6 | SMILES: | O=C(O)CCCC(O)/C=C/C(=CC(C)CC(=CC=CC(O)C1OC(/C=C/C)C(C(O)C1)C)C)C | InChi: | InChI=1S/C28H44O6/c1-6-9-26-22(5)25(31)18-27(34-26)24(30)12-7-10-19(2)16-21(4)17-20(3)14-15-23(29)11-8-13-28(32)33/h6-7,9-10,12,14-15,17,21-27,29-31H,8,11,13,16,18H2,1-5H3,(H,32,33)/b9-6+,12-7+,15-14+,19-10+,20-17-/t21-,22+,23-,24-,25-,26+,27-/m1/s1 | Definition date: | 2012-10-11 | Last modified: | 2024-09-27 | Release date: | 2013-01-04 | Identifier: | (1S,5R)-1,5-anhydro-5-[(1R,2E,4E,7R,8Z,10E,12R)-15-carboxy-1,12-dihydroxy-5,7,9-trimethylpentadeca-2,4,8,10-tetraen-1-yl]-2,4-dideoxy-2-methyl-1-[(1E)-prop-1-en-1-yl]-D-threo-pentitol |
|
 | SC2 | Name: | N-ACETYL-L-CYSTEINE | Formula: | C5 H9 N O3 S | SMILES: | O=C(NC(C(=O)O)CS)C | InChi: | InChI=1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1 | Synonyms: | (2R)-2-acetamido-3-sulfanyl-propanoic acid | Definition date: | 2006-08-11 | Last modified: | 2024-09-27 | Identifier: | N-acetyl-L-cysteine |
|
 | QCL | Name: | 8-azanyl-4-(2-ethylbutoxy)quinoline-2-carbaldehyde | Formula: | C16 H20 N2 O3 | SMILES: | CCC(CC)COc1cc(nc2c(N)cccc12)C(O)=O | InChi: | InChI=1S/C16H20N2O3/c1-3-10(4-2)9-21-14-8-13(16(19)20)18-15-11(14)6-5-7-12(15)17/h5-8,10H,3-4,9,17H2,1-2H3,(H,19,20) | Definition date: | 2016-06-01 | Last modified: | 2024-09-27 | Release date: | 2017-06-21 | Identifier: | 8-azanyl-4-(2-ethylbutoxy)quinoline-2-carboxylic acid |
|
 | UDP | Name: | URIDINE-5'-DIPHOSPHATE | Formula: | C9 H14 N2 O12 P2 | SMILES: | O=P(O)(O)OP(=O)(O)OCC2OC(N1C(=O)NC(=O)C=C1)C(O)C2O | InChi: | InChI=1S/C9H14N2O12P2/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(22-8)3-21-25(19,20)23-24(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,10,12,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | uridine 5'-(trihydrogen diphosphate) |
|
 | SRB | Name: | L-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID | Formula: | C14 H17 B N O4 | SMILES: | O=C(NC([B-](O)(O)O)Cc2cccc1ccccc12)C | InChi: | InChI=1S/C14H17BNO4/c1-10(17)16-14(15(18,19)20)9-12-7-4-6-11-5-2-3-8-13(11)12/h2-8,14,18-20H,9H2,1H3,(H,16,17)/q-1/t14-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | [(1R)-1-(acetylamino)-2-naphthalen-1-ylethyl](trihydroxy)borate(1-) |
|
 | VKH | Name: | (1~{R},2~{R},3~{S},4~{R},5~{R},6~{R})-5-(hydroxymethyl)-7-azabicyclo[4.1.0]heptane-2,3,4-triol | Formula: | C7 H16 N O4 | SMILES: | [NH3+][CH]1C[CH](O)[CH](O)[CH](O)[CH]1CO | InChi: | InChI=1S/C7H15NO4/c8-4-1-5(10)7(12)6(11)3(4)2-9/h3-7,9-12H,1-2,8H2/p+1/t3-,4-,5+,6+,7+/m0/s1 | Definition date: | 2021-05-25 | Last modified: | 2024-09-27 | Release date: | 2022-02-02 | Identifier: | [(1~{S},2~{R},3~{R},4~{R},5~{R})-2-(hydroxymethyl)-3,4,5-tris(oxidanyl)cyclohexyl]azanium |
|
 | TYW | Name: | (2S)-2-amino-3-(4-hydroxyphenyl)propane-1,1-diol | Formula: | C9 H13 N O3 | SMILES: | Oc1ccc(cc1)CC(N)C(O)O | InChi: | InChI=1S/C9H13NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8-9,11-13H,5,10H2/t8-/m0/s1 | Definition date: | 2011-09-27 | Last modified: | 2024-09-27 | Identifier: | (2S)-2-amino-3-(4-hydroxyphenyl)propane-1,1-diol |
|
 | XOO | Name: | 4-{2-[({4-[(2P)-2-(2-aminopyridin-3-yl)-5-phenyl-3H-imidazo[4,5-b]pyridin-3-yl]phenyl}methyl)amino]ethyl}-2-hydroxybenzaldehyde | Formula: | C33 H28 N6 O2 | SMILES: | O=Cc1ccc(cc1O)CCNCc1ccc(cc1)n1c2nc(ccc2nc1c1cccnc1N)c1ccccc1 | InChi: | InChI=1S/C33H28N6O2/c34-31-27(7-4-17-36-31)32-38-29-15-14-28(24-5-2-1-3-6-24)37-33(29)39(32)26-12-9-23(10-13-26)20-35-18-16-22-8-11-25(21-40)30(41)19-22/h1-15,17,19,21,35,41H,16,18,20H2,(H2,34,36) | Definition date: | 2023-11-06 | Last modified: | 2024-09-27 | Release date: | 2024-09-04 | Identifier: | 4-{2-[({4-[(2P)-2-(2-aminopyridin-3-yl)-5-phenyl-3H-imidazo[4,5-b]pyridin-3-yl]phenyl}methyl)amino]ethyl}-2-hydroxybenzaldehyde |
|
 | ZEK | Name: | 3-acetamido-N-methylbenzamide | Formula: | C10 H12 N2 O2 | SMILES: | O=C(C)Nc1cc(ccc1)C(=O)NC | InChi: | InChI=1S/C10H12N2O2/c1-7(13)12-9-5-3-4-8(6-9)10(14)11-2/h3-6H,1-2H3,(H,11,14)(H,12,13) | Definition date: | 2023-06-23 | Last modified: | 2024-09-27 | Release date: | 2023-07-12 | Identifier: | 3-acetamido-N-methylbenzamide |
|
 | WEH | Name: | L-Homoglutamine | Formula: | C6 H12 N2 O3 | SMILES: | N[CH](CCCC(N)=O)C(O)=O | InChi: | InChI=1S/C6H12N2O3/c7-4(6(10)11)2-1-3-5(8)9/h4H,1-3,7H2,(H2,8,9)(H,10,11)/t4-/m1/s1 | Synonyms: | (2~{S})-2,6-bis(azanyl)-6-oxidanylidene-hexanoic acid | Definition date: | 2023-10-03 | Last modified: | 2024-09-27 | Release date: | 2024-03-27 | Identifier: | (2~{S})-2,6-bis(azanyl)-6-oxidanylidene-hexanoic acid |
|
 | QCN | Name: | (2~{S})-2-azanyl-3-(3-~{tert}-butyl-4-oxidanyl-phenyl)propanal | Formula: | C13 H19 N O3 | SMILES: | CC(C)(C)c1cc(C[CH](N)C(O)=O)ccc1O | InChi: | InChI=1S/C13H19NO3/c1-13(2,3)9-6-8(4-5-11(9)15)7-10(14)12(16)17/h4-6,10,15H,7,14H2,1-3H3,(H,16,17)/t10-/m0/s1 | Definition date: | 2020-06-05 | Last modified: | 2024-09-27 | Release date: | 2021-06-30 | Identifier: | (2~{S})-2-azanyl-3-(3-~{tert}-butyl-4-oxidanyl-phenyl)propanoic acid |
|
 | TYX | Name: | S-(2-ANILINO-2-OXOETHYL)-L-CYSTEINE | Formula: | C11 H14 N2 O3 S | SMILES: | O=C(Nc1ccccc1)CSCC(C(=O)O)N | InChi: | InChI=1S/C11H14N2O3S/c12-9(11(15)16)6-17-7-10(14)13-8-4-2-1-3-5-8/h1-5,9H,6-7,12H2,(H,13,14)(H,15,16)/t9-/m0/s1 | Definition date: | 2007-05-07 | Last modified: | 2024-09-27 | Identifier: | S-[2-oxo-2-(phenylamino)ethyl]-L-cysteine |
|
 | SRD | Name: | D-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID | Formula: | C14 H17 B N O4 | SMILES: | O=C(NC([B-](O)(O)O)Cc2cccc1ccccc12)C | InChi: | InChI=1S/C14H17BNO4/c1-10(17)16-14(15(18,19)20)9-12-7-4-6-11-5-2-3-8-13(11)12/h2-8,14,18-20H,9H2,1H3,(H,16,17)/q-1/t14-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | [(1S)-1-(acetylamino)-2-naphthalen-1-ylethyl](trihydroxy)borate(1-) |
|
 | XOP | Name: | 8-METHYL-8-AZABICYCLO[3.2.1]OCTAN-3-YL PHENYLPHOSPHONATE | Formula: | C14 H20 N O3 P | SMILES: | OP(OC2CC1N(C)C(CC1)C2)c3ccccc3 | InChi: | InChI=1S/C14H20NO3P/c1-15-11-7-8-12(15)10-13(9-11)18-19(16,17)14-5-3-2-4-6-14/h2-6,11-13H,7-10H2,1H3,(H,16,17)/t11-,12+,13+ | Definition date: | 2010-11-25 | Last modified: | 2024-09-27 | Identifier: | (3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl hydrogen (R)-phenylphosphonite |
|
 | X9Q | Name: | {(2S)-2-[(1S)-1-AMINOETHYL]-4-BENZYL-5-OXO-2,5-DIHYDRO-1H-IMIDAZOL-1-YL}ACETIC ACID | Formula: | C14 H17 N3 O3 | SMILES: | O=C1C(=NC(N1CC(=O)O)C(N)C)Cc2ccccc2 | InChi: | InChI=1S/C14H17N3O3/c1-9(15)13-16-11(7-10-5-3-2-4-6-10)14(20)17(13)8-12(18)19/h2-6,9,13H,7-8,15H2,1H3,(H,18,19)/t9-,13-/m0/s1 | Synonyms: | CHROMOPHORE (ALA, PHE, GLY) | Definition date: | 2007-03-22 | Last modified: | 2024-09-27 | Identifier: | {(2S)-2-[(1S)-1-aminoethyl]-4-benzyl-5-oxo-2,5-dihydro-1H-imidazol-1-yl}acetic acid |
|
 | TYY | Name: | 3-(4-HYDROXY-3-IMINO-6-OXO-CYCLOHEXA-1,4-DIENYL)-ALANINE | Formula: | C9 H10 N2 O4 | SMILES: | O=C1C=C(O)C(=[N@H])C=C1CC(C(=O)O)N | InChi: | InChI=1S/C9H10N2O4/c10-5-1-4(2-6(11)9(14)15)7(12)3-8(5)13/h1,3,6,10,13H,2,11H2,(H,14,15)/b10-5-/t6-/m0/s1 | Definition date: | 1999-08-26 | Last modified: | 2024-09-27 | Identifier: | 3-[(3Z)-4-hydroxy-3-imino-6-oxocyclohexa-1,4-dien-1-yl]-L-alanine |
|
 | RXR | Name: | [2,2,5,5-tetramethyl-3,4-bis(sulfanylmethyl)-2,5-dihydro-1H-pyrrol-1-yl]oxidanyl radical | Formula: | C10 H18 N O S2 | SMILES: | ON1C(C(=C(CS)C1(C)C)CS)(C)C | InChi: | InChI=1S/C10H19NOS2/c1-9(2)7(5-13)8(6-14)10(3,4)11(9)12/h12-14H,5-6H2,1-4H3 | Synonyms: | 3,4-bis(thiomethyl)-2,2,5,5-tetramethyl-1H-Pyrrol-1-yloxyl radical | Definition date: | 2010-01-08 | Last modified: | 2024-09-27 | Identifier: | 2,2,5,5-tetramethyl-3,4-bis(sulfanylmethyl)-2,5-dihydro-1H-pyrrol-1-ol |
|
 | VKL | Name: | 3-[3,4-bis(fluoranyl)phenyl]-5-methyl-1$l^{4},4,5$l^{4},7-tetrazabicyclo[4.3.0]nona-1(6),2,4-triene | Formula: | C12 H12 F2 N4 | SMILES: | C[n+]1nc(c[n+]2CCNc12)c3ccc(F)c(F)c3 | InChi: | InChI=1S/C12H11F2N4/c1-17-12-15-4-5-18(12)7-11(16-17)8-2-3-9(13)10(14)6-8/h2-3,6-7H,4-5H2,1H3/q+1/p+1 | Definition date: | 2023-03-09 | Last modified: | 2024-09-27 | Release date: | 2023-05-24 | Identifier: | 3-[3,4-bis(fluoranyl)phenyl]-1-methyl-7,8-dihydro-6~{H}-imidazo[2,1-c][1,2,4]triazine-1,5-diium |
|
 | TYZ | Name: | PARA ACETAMIDO BENZOIC ACID | Formula: | C9 H9 N O3 | SMILES: | O=C(Nc1ccc(cc1)C(=O)O)C | InChi: | InChI=1S/C9H9NO3/c1-6(11)10-8-4-2-7(3-5-8)9(12)13/h2-5H,1H3,(H,10,11)(H,12,13) | Definition date: | 2004-08-07 | Last modified: | 2024-09-27 | Identifier: | 4-(acetylamino)benzoic acid |
|
 | TZ0 | Name: | 1-[(3S)-3-{4-amino-3-[(3,5-dimethoxyphenyl)ethynyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl}pyrrolidin-1-yl]prop-2-en-1-one | Formula: | C22 H22 N6 O3 | SMILES: | COc1cc(OC)cc(c1)C#Cc3c2c(ncnc2N)n(n3)C4CN(CC4)C([C@H]=C)=O | InChi: | InChI=1S/C22H22N6O3/c1-4-19(29)27-8-7-15(12-27)28-22-20(21(23)24-13-25-22)18(26-28)6-5-14-9-16(30-2)11-17(10-14)31-3/h4,9-11,13,15H,1,7-8,12H2,2-3H3,(H2,23,24,25)/t15-/m0/s1 | Definition date: | 2018-11-06 | Last modified: | 2024-09-27 | Release date: | 2019-01-16 | Identifier: | 1-[(3S)-3-{4-amino-3-[(3,5-dimethoxyphenyl)ethynyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl}pyrrolidin-1-yl]prop-2-en-1-one |
|
 | SRG | Name: | (2S)-2-[[(2S)-1-[[(5S,8S,9E)-2,7-dioxo-5-propan-2-yl-1,6-diazacyclododeca-3,9-dien-8-yl]amino]-3-methyl-1-oxo-butan-2-yl]carbamoylamino]-3-methyl-butanoic acid | Formula: | C24 H39 N5 O6 | SMILES: | O=C(O)C(NC(=O)NC(C(=O)NC1C(=O)NC(C=CC(=O)NCCC=C1)C(C)C)C(C)C)C(C)C | InChi: | InChI=1S/C24H39N5O6/c1-13(2)16-10-11-18(30)25-12-8-7-9-17(21(31)26-16)27-22(32)19(14(3)4)28-24(35)29-20(15(5)6)23(33)34/h7,9-11,13-17,19-20H,8,12H2,1-6H3,(H,25,30)(H,26,31)(H,27,32)(H,33,34)(H2,28,29,35)/b9-7+,11-10?/t16-,17+,19+,20+/m1/s1 | Synonyms: | Syringolin A | Definition date: | 2007-11-20 | Last modified: | 2024-09-27 | Identifier: | N-{[(1S)-2-methyl-1-{[(3E,5S,8S,9E)-5-(1-methylethyl)-2,7-dioxo-1,6-diazacyclododeca-3,9-dien-8-yl]carbamoyl}propyl]carbamoyl}-L-valine |
|
 | WU5 | Name: | (5R)-1-fluoro-5-[(1R,3aS,3bR,5aR,7R,9aS,9bS,11aR)-7-hydroxy-9a,11a-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]hexan-2-one (non-preferred name) | Formula: | C25 H41 F O2 | SMILES: | FCC(=O)CCC(C)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C | InChi: | InChI=1S/C25H41FO2/c1-16(4-6-19(28)15-26)21-8-9-22-20-7-5-17-14-18(27)10-12-24(17,2)23(20)11-13-25(21,22)3/h16-18,20-23,27H,4-15H2,1-3H3/t16-,17-,18-,20+,21-,22+,23+,24+,25-/m1/s1 | Definition date: | 2022-10-19 | Last modified: | 2024-09-27 | Release date: | 2023-11-01 | Identifier: | (5R)-1-fluoro-5-[(1R,3aS,3bR,5aR,7R,9aS,9bS,11aR)-7-hydroxy-9a,11a-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]hexan-2-one (non-preferred name) |
|